These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 9202403

  • 21. Two tandemly linked interferon-gamma-activated sequence elements in the promoter of glycosylation-dependent cell adhesion molecule 1 gene synergistically respond to prolactin in mouse mammary epithelial cells.
    Hou Z, Srivastava S, Mistry MJ, Herbst MP, Bailey JP, Horseman ND.
    Mol Endocrinol; 2003 Oct; 17(10):1910-20. PubMed ID: 12869589
    [Abstract] [Full Text] [Related]

  • 22. Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout mice.
    Wagner KU, Krempler A, Triplett AA, Qi Y, George NM, Zhu J, Rui H.
    Mol Cell Biol; 2004 Jun; 24(12):5510-20. PubMed ID: 15169911
    [Abstract] [Full Text] [Related]

  • 23. Cytokine-like effects of prolactin in human mononuclear and polymorphonuclear leukocytes.
    Dogusan Z, Hooghe R, Verdood P, Hooghe-Peters EL.
    J Neuroimmunol; 2001 Nov 01; 120(1-2):58-66. PubMed ID: 11694320
    [Abstract] [Full Text] [Related]

  • 24. Proline-rich sequence-mediated Jak2 association to the prolactin receptor is required but not sufficient for signal transduction.
    Lebrun JJ, Ali S, Ullrich A, Kelly PA.
    J Biol Chem; 1995 May 05; 270(18):10664-70. PubMed ID: 7537736
    [Abstract] [Full Text] [Related]

  • 25. Characterization of a rat uterine cell line, U(III) cells: prolactin (PRL) expression and endogenous regulation of PRL-dependent genes; estrogen receptor beta, alpha(2)-macroglobulin, and decidual PRL involving the Jak2 and Stat5 pathway.
    Prigent-Tessier A, Barkai U, Tessier C, Cohen H, Gibori G.
    Endocrinology; 2001 Mar 05; 142(3):1242-50. PubMed ID: 11181541
    [Abstract] [Full Text] [Related]

  • 26. Receptor activator of NF-kappaB ligand induction via Jak2 and Stat5a in mammary epithelial cells.
    Srivastava S, Matsuda M, Hou Z, Bailey JP, Kitazawa R, Herbst MP, Horseman ND.
    J Biol Chem; 2003 Nov 14; 278(46):46171-8. PubMed ID: 12952963
    [Abstract] [Full Text] [Related]

  • 27. SOCS-1, -2, -3: selective targets and functions downstream of the prolactin receptor.
    Tomic S, Chughtai N, Ali S.
    Mol Cell Endocrinol; 1999 Dec 20; 158(1-2):45-54. PubMed ID: 10630404
    [Abstract] [Full Text] [Related]

  • 28. Activation of the Jak2-Stat5 signaling pathway in Nb2 lymphoma cells by an anti-apoptotic agent, aurintricarboxylic acid.
    Rui H, Xu J, Mehta S, Fang H, Williams J, Dong F, Grimley PM.
    J Biol Chem; 1998 Jan 02; 273(1):28-32. PubMed ID: 9417042
    [Abstract] [Full Text] [Related]

  • 29. Differential effects of prolactin and src/abl kinases on the nuclear translocation of STAT5B and STAT5A.
    Kazansky AV, Kabotyanski EB, Wyszomierski SL, Mancini MA, Rosen JM.
    J Biol Chem; 1999 Aug 06; 274(32):22484-92. PubMed ID: 10428824
    [Abstract] [Full Text] [Related]

  • 30. Dissociation of Janus kinase 2 and signal transducer and activator of transcription 5 activation after treatment of Nb2 cells with a molecular mimic of phosphorylated prolactin.
    Coss D, Kuo CB, Yang L, Ingleton P, Luben R, Walker AM.
    Endocrinology; 1999 Nov 06; 140(11):5087-94. PubMed ID: 10537136
    [Abstract] [Full Text] [Related]

  • 31. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase.
    Yi W, Kim SO, Jiang J, Park SH, Kraft AS, Waxman DJ, Frank SJ.
    Mol Endocrinol; 1996 Nov 06; 10(11):1425-43. PubMed ID: 8923468
    [Abstract] [Full Text] [Related]

  • 32. Distinct cytoplasmic regions of the growth hormone receptor are required for activation of JAK2, mitogen-activated protein kinase, and transcription.
    Sotiropoulos A, Perrot-Applanat M, Dinerstein H, Pallier A, Postel-Vinay MC, Finidori J, Kelly PA.
    Endocrinology; 1994 Oct 06; 135(4):1292-8. PubMed ID: 7925092
    [Abstract] [Full Text] [Related]

  • 33. A single phosphotyrosine residue of the prolactin receptor is responsible for activation of gene transcription.
    Lebrun JJ, Ali S, Goffin V, Ullrich A, Kelly PA.
    Proc Natl Acad Sci U S A; 1995 Apr 25; 92(9):4031-5. PubMed ID: 7537382
    [Abstract] [Full Text] [Related]

  • 34. Dominant negative and cooperative effects of mutant forms of prolactin receptor.
    Perrot-Applanat M, Gualillo O, Pezet A, Vincent V, Edery M, Kelly PA.
    Mol Endocrinol; 1997 Jul 25; 11(8):1020-32. PubMed ID: 9212050
    [Abstract] [Full Text] [Related]

  • 35. Prolactin recruits STAT1, STAT3 and STAT5 independent of conserved receptor tyrosines TYR402, TYR479, TYR515 and TYR580.
    DaSilva L, Rui H, Erwin RA, Howard OM, Kirken RA, Malabarba MG, Hackett RH, Larner AC, Farrar WL.
    Mol Cell Endocrinol; 1996 Mar 25; 117(2):131-40. PubMed ID: 8737372
    [Abstract] [Full Text] [Related]

  • 36. An immunohistochemical approach to monitor the prolactin-induced activation of the JAK2/STAT5 pathway in pancreatic islets of Langerhans.
    Brelje TC, Svensson AM, Stout LE, Bhagroo NV, Sorenson RL.
    J Histochem Cytochem; 2002 Mar 25; 50(3):365-83. PubMed ID: 11850439
    [Abstract] [Full Text] [Related]

  • 37. Differential activation of Stat3 and Stat5 by distinct regions of the growth hormone receptor.
    Sotiropoulos A, Moutoussamy S, Renaudie F, Clauss M, Kayser C, Gouilleux F, Kelly PA, Finidori J.
    Mol Endocrinol; 1996 Aug 25; 10(8):998-1009. PubMed ID: 8843416
    [Abstract] [Full Text] [Related]

  • 38. Contrasting acute in vivo nuclear actions of growth hormone and prolactin.
    Le Stunff C, Gronowski AM, Rotwein P.
    Mol Cell Endocrinol; 1996 Aug 09; 121(2):109-17. PubMed ID: 8892312
    [Abstract] [Full Text] [Related]

  • 39. Stoichiometric structure-function analysis of the prolactin receptor signaling domain by receptor chimeras.
    Chang WP, Ye Y, Clevenger CV.
    Mol Cell Biol; 1998 Feb 09; 18(2):896-905. PubMed ID: 9447986
    [Abstract] [Full Text] [Related]

  • 40. Different biological effects of unmodified prolactin and a molecular mimic of phosphorylated prolactin involve different signaling pathways.
    Wu W, Coss D, Lorenson MY, Kuo CB, Xu X, Walker AM.
    Biochemistry; 2003 Jun 24; 42(24):7561-70. PubMed ID: 12809512
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.